SG10201913433SA - Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives - Google Patents

Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives

Info

Publication number
SG10201913433SA
SG10201913433SA SG10201913433SA SG10201913433SA SG10201913433SA SG 10201913433S A SG10201913433S A SG 10201913433SA SG 10201913433S A SG10201913433S A SG 10201913433SA SG 10201913433S A SG10201913433S A SG 10201913433SA SG 10201913433S A SG10201913433S A SG 10201913433SA
Authority
SG
Singapore
Prior art keywords
insulin
pharmaceutical formulations
stabilized pharmaceutical
derivatives
analogues
Prior art date
Application number
SG10201913433SA
Other languages
English (en)
Inventor
Oliver Bley
Petra Loos
Bernd Bidlingmaier
Walter Kamm
Harald Berchtold
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of SG10201913433SA publication Critical patent/SG10201913433SA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1825Fibroblast growth factor [FGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/26Glucagons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SG10201913433SA 2013-02-04 2014-02-03 Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives SG10201913433SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13305126 2013-02-04
US201361761434P 2013-02-06 2013-02-06

Publications (1)

Publication Number Publication Date
SG10201913433SA true SG10201913433SA (en) 2020-03-30

Family

ID=66013563

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10201913433SA SG10201913433SA (en) 2013-02-04 2014-02-03 Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives

Country Status (5)

Country Link
JP (2) JP6698797B2 (es)
ES (1) ES2804719T3 (es)
PT (1) PT2950780T (es)
RU (1) RU2019128331A (es)
SG (1) SG10201913433SA (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2804719T3 (es) * 2013-02-04 2021-02-09 Sanofi Sa Formulaciones farmacéuticas estabilizadas de análogos de insulina y/o derivados de insulina
CN110721154A (zh) * 2019-10-28 2020-01-24 南京圣鼎医药科技有限公司 一种恩格列净口服溶液及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63107941A (ja) * 1985-11-28 1988-05-12 Wakunaga Pharmaceut Co Ltd 制ガン剤
JP5715418B2 (ja) * 2007-11-08 2015-05-07 ノボ・ノルデイスク・エー/エス インスリン誘導体
AR075998A1 (es) * 2009-04-01 2011-05-11 Genentech Inc Tratamiento de trastornos resistentes a insulina.composicion farmaceutica. uso. kit
CN102470165B (zh) * 2009-06-26 2014-12-24 诺沃-诺迪斯克有限公司 包含胰岛素、烟酰胺和氨基酸的制剂
CN103249427A (zh) * 2010-12-14 2013-08-14 诺沃—诺迪斯克有限公司 速效胰岛素联合长效胰岛素
MX340172B (es) * 2011-06-17 2016-06-28 Halozyme Inc Formulaciones estables de una enzima degradadora de hialuronano.
ES2804719T3 (es) * 2013-02-04 2021-02-09 Sanofi Sa Formulaciones farmacéuticas estabilizadas de análogos de insulina y/o derivados de insulina

Also Published As

Publication number Publication date
PT2950780T (pt) 2020-07-07
ES2804719T3 (es) 2021-02-09
RU2019128331A (ru) 2019-12-16
JP2020128395A (ja) 2020-08-27
JP6698797B2 (ja) 2020-05-27
JP2019052162A (ja) 2019-04-04

Similar Documents

Publication Publication Date Title
ZA201504582B (en) Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
SG11201604710XA (en) Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
SG11201604708VA (en) Stabilized glycerol free pharmaceutical formulations of insulin analogues and/or insulin derivatives
IL274841A (en) A stabilized formulation with a controlled release of vitamin D, and methods for its administration
IL240290A0 (en) History of pyridazinone-amide and pharmaceutical preparations containing them
HK1225613A1 (zh) 賴谷胰島素的穩定製劑
SG11201604706TA (en) Stabilized pharmaceutical formulations of insulin aspart
EP4005604C0 (en) ADMINISTRATION OF MEDICINES
HK1221152A1 (zh) 用於呋塞米的皮下施用的藥物製劑
HK1218079A1 (zh) 亞硝酸鹽的藥物製劑及其用途
HK1211594A1 (en) Human relaxin analogue, pharmaceutical composition of same, and pharmaceutical application of same
IL240292B (en) History of quinazoline and pharmaceutical preparations containing them
SG10201913433SA (en) Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
GB201307082D0 (en) Pharmaceutical composition comprising 15-HETrE and methods of using the same
BR112015016331A2 (pt) formulação farmacêutica estabilizada e método de estabilização de uma composição compreendendo voriconazol
EP3072873A4 (en) Vitamin d analogues of pharmaceutical interest
GB201319437D0 (en) Delivery of drugs